Human Malignant Melanoma by MacKie, R. M.
958 BOOK REVIEWS
represent the interest and idiosyncrasies of
the editors and, as often occurs, the delay
between data availability and publication
necessarily means that many of the studies
have been up-dated several times by the
publication of this particular volume. None
the less this book is a further volume in an
important series ofup-dates for thepractising
cancer clinician, and will find its way into his
library as before.
With the advent of specialist monographs
on many of the subjects covered here, one
might question thevalidity ofsuch a volume,
but for the eclectic and broadly based reader
the Year Book o Cancer still provides man f y
interesting items of information from a very
wide area of cancer clinical practice and re-
search, and is thoroughly recommended on
that ground alone.
H. Busi-i
Topics in Toxicology: Mutagenesis in
Sub-Mammalian Systems. Status and
Significance. ED. G. E. PAGET (1979).
M.T.P. Press. 231 pp. Y,8.95.
The book covers theproceedings of a meet-
ing held under the auspices of Inveresk Re-
search International to discuss topics of cur-
rent interest ingenetictoxicology. It contains
a mixed bag of papers of variable scientific
standard on topics ranging from the sig-
nificance of DNA damage for man to discus-
sion ofpracticallaboratory details in relation
to the Ames test. The book purports to be
about sub-mammalian systems, but some
papers deal, albeit in a rather superficial
manner, with DNA-repair tests, point muta-
tion and transformation assays in mammalian
ce,11s. The participants of the meeting were
mainly from industriallaboratories, and their
discussion of the various tests is largely con-
cerned with their usefulness in large-scale
screening, their validation and the problems
oftesting unknown compounds. As such, the
book isprobably ofinterest to those involved
in such testing, but of limited value to the
general scientific community because of the
superficial coverage ofmost ofthetopics, and
because most of the information is available
in a much more detailed form in the general
scientific literature. There have been numer-
ous such publications recently and this one
certainly adds little (ifany) new information.
M. Fox
Human Malignant Melanoma. Eds. W. H.
CLARK, L. 1. GOLDMAN and M. J. MASTRAN-
GELO (1979) ClinicalOncologyMonographs.
New York: Grune & Stratton. 509 pp.
Inthepastfewyearsseveraltextbookshave
appeared on the subject of malignant
melanoma, and it is therefore important to
examine new books of this type as they are
published to see just what part of the gaps
in our knowledge of this important condition
are being filled. This particular monograph is
mainly the work of the Philadelphia group,
and is an important and useful contribution
to ourknowledge. It has 3 sections. The first,
and by far the largest, is devoted to primary
cutaneousmalignant melanoma, and includes
discussion of the concept of tumour progres-
sion, detailed descriptions of pathology, and
discussion on some of the aspects of epi-
demiology of current importance. Section
two concerns the treatment of cutaneous
human malignant melanoma, and covers sur-
gery, perfusion, post-surgical adjuvant ther-
apy, chemotherapy, immunotherapy and
irradiation. The third section is on ocular
melanomas and covers malignant melanoma
of both the conjunctiva and the uveal tract.
I found this particularly valuable, in view of
the lack ofworkcurrently available on ocular
inalignant melanoma.
New points which are brought out in this
publicationincludetheseparation ofanentity
called a pigmented spindle-cell tumour from
the Spitz tumour/juvenile melanoma. In the
section onpathology the concept ofthe prog-
nostic value of both depth of tumour (ad-
vanced by Clark) and the thickness of the
tumour (advocated by Breslow) are dis-
cussed, but as more laboratories without par-
ticular knowledge of melanoma are now
measuring these parameters and including
them in routine reports to clinicians, some
critical discussion would be useful For
example, it is clear that tumour thickness
will varyaccording to the fixative, thelength
of time in fixative and the subsequent pro-
cessing. It would be valuable if one of the
laboratories which handle large quantities of
melanoma could study the effect of these
variables on tumour thickness. The discussion
on malignant melanoma of the oral cavity
underlines that this is an underworked area
badly needing further studies, by dermatolo-
gists or specialists in oral medicine.
In section two thesurgical results discussedBOOK REVIEWS 959
by Goldman emphasize the value of a small
group of experts handling large numbers of
malignant melanoma, and good 51-year sur-
vival data arereported from this group. Limb
perfusion would appear to be less advan-
tageous for the patient than could be hoped,
and post-surgical adjuvant therapy and
chemotherapy are discussed, and the current
disappointing results of chemotherapy em-
phasized. The highlight of this part of the
book, however, is an excellent chapter on the
immunology and immunotherapy of human
cutaneous malignant melanoma by Mastran-
gelo, Bellet and Berd. This chapter is an
excellent critical account of our current
understanding of the immunology of malig-
nant melanoma, and includes a first-class
critique of the technique of lymphocyte-
mediated cytotoxicity and the variables
which may influence the results in labora-
tories using this technique. Radiotherapy is
dealt withbriefly, and there is aplea for more
studies on the basic radiation biology of the
melanocyte.
In the third sectionmalignant melanoma of
the conjunctiva is dealt with relatively briefly, but thepoint is made that the 3 types of malignant melanoma recognized by Clark
inskin(viz.,lentigomalignamelanoma, super- ficial spreading melanoma and nodular
melanoma) are all found on the conjunctiva.
Malignant melanoma of the uveal tract is
discussed more fully, and it is interesting to
note that the ophtbalmologists have a diag-
nostic test which gives them 96% accuracy in the diagnosis ofmalignant tumours of the
eye. This is the measurement of the uptake of 32p, and if this statement is correct it is
surprising that thetechnique is not used more
widely by ophthalmologists. It is interesting that cell type in uveal-tract melanomas is
such an important prognostic factor, in con-
trast to its apparent lack ofprognostic value
in malignant melanomas of the skin. One
wonders whether the spindle-cell tumours,
particularly spindle-cell A with a 95% 5-year survival, is not perhaps a variant of benign
naevus and a form ofSpitz-cell tumour ofthe
uveal tract.
All in all, this is a book which can be
thoroughly recommended to workers in the
field of malignant melanoma. It is a book
which will be ofmost value to individuals who
already have some knowledge of melanoma
rather than the newcomer to the field. Prin-
ter's errors are relatively common but
detract little from the general value of the
book.
R. M. MAcKIE
Paraneoplasia: Biological Signals in the
Diagnosis of Cancer. J. G. WALDEN-
STR6M (1978). John Wiley & Sons. 173 pp.
E14.00.
It is good to see a clinical review on the
subject of Paraneoplastic Syndromes. The
subject is generally multidisciplinary, and
hence reviews and articles tend to be written
by biochemists and biologists who are not
often in contact with patients with the
syndromes under discussion.
Professor Waldenstrbm has presented us
with his own personal account ofthe subject,
and gives us the benefit of a wide and varied
clinical experience tempered by his extensive
knowledge ofbiochemistry.
The book has been divided into two parts:
Part I entitled "Signals from Organ Systems
indicating the presence of Neoplasia", with
6 chapters each dealing with a single organ,
and Part 2 entitled "General signals and
scientific substances indicating Neoplasia"
with 5 chapters outlining the "non-specific"
vmptoms of cancer, "Specific" biochemical
abnormalities, tumours that produce "euto-
pic" products and tumours that are asso-
ciated with "ectopic" hormone production.
On the whole this layout works well, since
we are not confined to the well-recognized syndromes such as tumour-associated Cush-
ing's syndrome, but we are also told about
many other much less "specific" tumour-
associated syndromes such as clotting abnor-
malities that commonly present problems to
the clinician managing patients with cancer.
There are weaknesses in some of the chap-
ters, especially those dealing with syndromes
associated with "ectopic hormones". Al-
though thedevelopment ofthe radioimmuno-
assay in the early 1960s did much to help us
with treatment and monitoring of some
tumours, such as those secreting antidiuretic
hormone, a good deal of confusion has
resultedfrom theapplicationofradioimmuno-
assays to measuring the small amounts of
circulating peptides associated with cancer.
Thus, much of the recent work on ectopic parathyroid hormone, calcitonin, growth hormone, insulin and chorionicgonadotrophin subunits is now being re-evaluated, more